BALAXI PHARMACEUTICALS
|
BALAXI PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹10 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹3.04 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
Equity - Issued | ₹10 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹3.04 Cr |
Equity Paid Up | ₹10 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹3.04 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹10 Cr | - | - | - | - |
Total Reserves | ₹162 Cr | ₹103 Cr | ₹55 Cr | ₹18 Cr | ₹0.48 Cr |
Securities Premium | ₹19 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹0.12 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹143 Cr | ₹92 Cr | ₹44 Cr | ₹6.45 Cr | ₹0.32 Cr |
General Reserves | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.02 Cr |
Other Reserves | - | - | - | - | ₹0.03 Cr |
Reserve excluding Revaluation Reserve | ₹162 Cr | ₹103 Cr | ₹55 Cr | ₹18 Cr | ₹0.48 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹183 Cr | ₹113 Cr | ₹65 Cr | ₹28 Cr | ₹3.52 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | ₹0.87 Cr | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | ₹0.87 Cr | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹1.10 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.00 Cr | - |
Deferred Tax Assets | - | - | - | - | - |
Deferred Tax Liability | ₹1.10 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.00 Cr | - |
Other Long Term Liabilities | ₹1.69 Cr | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | - | - |
Total Non-Current Liabilities | ₹3.66 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.00 Cr | - |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹35 Cr | ₹49 Cr | ₹25 Cr | ₹4.85 Cr | ₹2.08 Cr |
Sundry Creditors | ₹35 Cr | ₹49 Cr | ₹25 Cr | ₹4.85 Cr | ₹2.08 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹2.81 Cr | ₹3.26 Cr | ₹0.14 Cr | ₹0.96 Cr | ₹0.04 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | - | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹2.81 Cr | ₹3.26 Cr | ₹0.14 Cr | ₹0.96 Cr | ₹0.04 Cr |
Short Term Borrowings | ₹11 Cr | ₹3.64 Cr | ₹3.66 Cr | - | - |
Secured ST Loans repayable on Demands | ₹4.99 Cr | ₹2.64 Cr | ₹0.33 Cr | - | - |
Working Capital Loans- Sec | ₹4.42 Cr | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹1.34 Cr | ₹1.00 Cr | ₹3.33 Cr | - | - |
Short Term Provisions | ₹5.06 Cr | ₹7.25 Cr | ₹6.01 Cr | ₹2.42 Cr | ₹0.47 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹5.06 Cr | ₹7.25 Cr | ₹6.01 Cr | ₹2.42 Cr | ₹0.47 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | - | - | - | - | - |
Total Current Liabilities | ₹53 Cr | ₹63 Cr | ₹35 Cr | ₹8.22 Cr | ₹2.59 Cr |
Total Liabilities | ₹240 Cr | ₹176 Cr | ₹100 Cr | ₹36 Cr | ₹6.11 Cr |
ASSETS | |||||
Gross Block | ₹44 Cr | ₹30 Cr | ₹2.75 Cr | ₹0.19 Cr | ₹0.01 Cr |
Less: Accumulated Depreciation | ₹2.35 Cr | ₹0.76 Cr | ₹0.30 Cr | - | - |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹41 Cr | ₹29 Cr | ₹2.45 Cr | ₹0.19 Cr | ₹0.01 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹2.83 Cr | ₹0.57 Cr | - | - | - |
Non Current Investments | - | - | ₹3.42 Cr | - | - |
Long Term Investment | - | - | ₹3.42 Cr | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | ₹3.42 Cr | - | - |
Long Term Loans & Advances | ₹1.52 Cr | ₹1.27 Cr | ₹0.05 Cr | ₹0.92 Cr | ₹0.32 Cr |
Other Non Current Assets | ₹0.40 Cr | ₹4.87 Cr | - | - | - |
Total Non-Current Assets | ₹46 Cr | ₹35 Cr | ₹5.91 Cr | ₹1.11 Cr | ₹0.33 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹105 Cr | ₹99 Cr | ₹14 Cr | ₹0.83 Cr | - |
Raw Materials | - | - | - | - | - |
Work-in Progress | - | - | - | - | - |
Finished Goods | - | - | - | - | - |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | - | - | - | - | - |
Other Inventory | ₹105 Cr | ₹99 Cr | ₹14 Cr | ₹0.83 Cr | - |
Sundry Debtors | ₹52 Cr | ₹28 Cr | ₹77 Cr | ₹30 Cr | ₹5.47 Cr |
Debtors more than Six months | ₹12 Cr | ₹13 Cr | - | - | - |
Debtors Others | ₹40 Cr | ₹15 Cr | ₹77 Cr | ₹30 Cr | ₹5.47 Cr |
Cash and Bank | ₹28 Cr | ₹7.19 Cr | ₹1.67 Cr | ₹4.00 Cr | ₹0.13 Cr |
Cash in hand | - | ₹0.62 Cr | ₹0.05 Cr | ₹0.01 Cr | ₹0.01 Cr |
Balances at Bank | ₹28 Cr | ₹6.57 Cr | ₹1.62 Cr | ₹3.99 Cr | ₹0.13 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹4.52 Cr | ₹3.90 Cr | ₹0.77 Cr | - | - |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹3.78 Cr | ₹3.12 Cr | ₹0.72 Cr | - | - |
Other current_assets | ₹0.74 Cr | ₹0.78 Cr | ₹0.05 Cr | - | - |
Short Term Loans and Advances | ₹3.47 Cr | ₹3.65 Cr | ₹0.95 Cr | ₹0.31 Cr | ₹0.17 Cr |
Advances recoverable in cash or in kind | ₹2.15 Cr | ₹2.37 Cr | ₹0.35 Cr | ₹0.31 Cr | ₹0.17 Cr |
Advance income tax and TDS | ₹0.67 Cr | ₹0.78 Cr | ₹0.61 Cr | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹0.65 Cr | ₹0.50 Cr | - | - | - |
Total Current Assets | ₹194 Cr | ₹141 Cr | ₹94 Cr | ₹35 Cr | ₹5.78 Cr |
Net Current Assets (Including Current Investments) | ₹140 Cr | ₹78 Cr | ₹59 Cr | ₹27 Cr | ₹3.19 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹240 Cr | ₹176 Cr | ₹100 Cr | ₹36 Cr | ₹6.11 Cr |
Contingent Liabilities | - | - | - | - | - |
Total Debt | ₹12 Cr | ₹3.64 Cr | ₹3.66 Cr | - | - |
Book Value | - | 113.16 | 64.98 | 27.75 | 11.58 |
Adjusted Book Value | 169.51 | 113.16 | 64.98 | 27.75 | 11.58 |
Compare Balance Sheet of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹643.5 Cr | 2.2% | 15% | 7.1% | Stock Analytics | |
ADANI ENTERPRISES | ₹351,109.0 Cr | 0.5% | -0.8% | 72.9% | Stock Analytics | |
REDINGTON | ₹17,402.3 Cr | 2.2% | 8.4% | 31.6% | Stock Analytics | |
HONASA CONSUMER | ₹13,911.7 Cr | 6.1% | 16% | NA | Stock Analytics | |
MMTC | ₹11,448.0 Cr | 5.3% | 14.8% | 155.7% | Stock Analytics | |
MSTC | ₹6,407.1 Cr | 4.7% | 6.3% | 242.8% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | 2.2% |
15% |
7.1% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses